In vivo glioma model enabling regulated gene expression

Area of Science:

• Neuro-oncology
• Molecular Biology
• Cancer Research

Background:

• Investigating glioma requires accurate models and gene expression control.
• Existing models may lack the necessary features for detailed study.
• Targeted gene regulation is crucial for understanding glioma development and therapy.

Purpose of the Study:

• To establish a novel in vivo rat glioma model.
• To enable precise transcriptional control of transgenes within the glioma model.
• To facilitate studies on glioma biology and experimental gene therapy.

Main Methods:

• Genetically modified rat C6 glioma cells (C6TL) were developed with a lacZ reporter and tetracycline-controlled transactivator (tTA).
• C6TL cells were intracerebrally transplanted into nude mice to form tumors resembling human malignant gliomas.
• Luciferase reporter gene expression was regulated using tetracycline in drinking water.

Main Results:

• The established C6TL cell tumors exhibited astrocytic phenotype and diffuse brain invasion, mimicking human gliomas.
• Beta-galactosidase histochemistry allowed for unequivocal identification of individual tumor cells.
• In vitro, luciferase activity showed a 23-fold regulation; in vivo, 4.5- to 8.3-fold regulation was achieved via tetracycline administration.

Conclusions:

• The developed rat glioma model offers a valuable tool for in vivo functional studies of candidate genes.
• This model supports experimental gene therapy research by allowing controlled gene expression.
• The model's histological resemblance to human gliomas and precise gene regulation enhance its utility in neuro-oncology research.